Introduction

B-chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of long-lived CD5
þ B cells. 1, 2 However, when cultured in vitro, B-CLL cells die quickly by apoptosis. 3, 4 Several lines of evidence support that nonmalignant cells and other host elements extrinsic to B-CLL cells provide survival signals to malignant clones in vivo. [5] [6] [7] [8] For instance, CD40 stimulation within lymphoid tissues appears to rescue B-CLL cells from apoptosis. [9] [10] [11] [12] [13] On the other hand, it has been described that mouse fibroblasts (Ltk À cell line) with addition of IL-4 (the CD40 system) are capable to support the survival and expansion of CLL-B cells in vitro. 14, 15 However, signaling pathways responsible for the malignant cell survival are poorly understood. Exploiting these pathways may be of value in the understanding of the disease pathogenesis and development of new therapeutic strategies for B-CLL.
The phosphatidylinositol-3 kinase (PI3K)/Akt cascade has been recently identified as a critical component of survival signaling.
16 PI3K-generated phospholipids bind to the serine/ threonine kinase Akt/protein kinase B (PKB), leading to its translocation from the cytoplasm to the inner surface of the plasma membrane. 17 Relocalization of Akt to the plasma membrane brings Akt in proximity to regulatory kinases (phosphoinositide 3-dependent kinases) that activate Akt by phosphorylation at Thr 308 and Ser 473 . 18, 19 Once activated, Akt inhibits cell death pathways by directly phosphorylating and inactivating proteins involved in apoptosis, including Bad, procaspase 9, and members of the Forkhead transcription factors family. [20] [21] [22] In addition, Akt has been implicated as a signaling intermediate upstream of survival gene expression that is dependent on the transcription factor NF-kB. [23] [24] [25] NF-kB is a collective name for inducible dimeric transcription factors composed of members of the Rel family of DNA-binding proteins that recognize a common sequence motif. Mammals express five NF-kB/Rel proteins: p50, p52, p65 (RelA), c-Rel, and RelB. 26 NF-kB homo/heterodimers containing different combination of these subunits are held in the cytoplasm through interaction with specific inhibitors, the IkBs (IkBa, IkBb, and IkBg). The IkBs undergo rapid ubiquitin-dependent degradation after exposure to a variety of agonists, which activate the IkB kinase (IKK) complex. 27 Activation of IKK has been shown to be mediated by upstream acting kinases including NIK, MEKK1, as well as Akt. 28 Once in the nucleus, NF-kB dimers are subjected to further regulation mainly through phosphorylation of the Rel proteins. Several signaling pathways, which induce the phosphatidylinositol-3 kinase (PI3-K)/Akt pathway, are thought to be involved in this process. 29 The genes induced by NF-kB to promote survival include cellular inhibitors of apoptosis (cIAPs), 30 FLICE (FADD-like IL-beta-converting enzyme)-inhibitory protein (FLIP), [31] [32] [33] [34] and the Bcl-2 homologous A1 and Bclx L . [35] [36] [37] Freshly isolated B-CLL cells have been shown to have high constitutive levels of NF-kB activity, 38 which might be attributable to the activation of either the Raf-MEK-ERK or/ and PI3-Kinase-Akt pathways. The aim of this study was to determine signaling pathways responsible for prolonged survival of B-CLL cells. We tested the hypothesis that a sustained basal PI3K activity is essential for the prevention of the spontaneous apoptosis of B-CLL cells in culture. Murine fibroblasts were used to mimic in vivo milieu.
Patients, materials, and methods
Patient specimens
Heparinized peripheral blood was obtained from 71 patients (47 men and 24 women with a mean age of 67 years (range 40À93)) diagnosed of B-CLL by standard clinical and laboratory criteria. 1 Patients were either untreated or had not received treatment for 3 months before the study. The study protocol was approved by the institutional review board of the participating centers and written informed consent was obtained from all patients.
Purification of B-CLL lymphocytes
Mononuclear cells were isolated from heparinized peripheral blood of CLL patients by Ficoll density-gradient centrifugation. Monocytes and T cells were depleted by magnetic bead separation using anti-CD2 and anti-CD14 magnetic beads (Dynabeads M450, Dynal Biotech, Oslo, Norway), according to the manufacturer's instructions. After purification, staining with selected monoclonal antibodies (MoAbs) verified that they were composed of greater than 95% of CD19 þ CD5 þ B cells.
Purification of normal B lymphocytes
Mononuclear cells were isolated from umbilical cord blood by centrifugation over a Ficoll-Hypaque layer. Immature erythrocytes were lysed using a solution containing 0.150 mM NH 4 Cl, 1 mM KHCO 3 , and 0.1 mM Na 2 EDTA (pH 7.3). B cells were purified by immunomagnetic selection techniques using a B-cell negative isolation kit (Dynal Biotech) containing a mixture of mouse MoAbs for CD2, CD3, CD7, CD14, CD16, and CD56, according to the manufacturer's instructions. To further deplete adherent cells, additional anti-CD11b antibody (BD Biosciences, Erembodegem-Aalst, Belgium) was added. Immunophenotyping verified that the cell population was composed of greater than 90% of CD19 þ , with more than 60% coexpressing CD5 þ .
Reagents and antibodies
MoAbs specific for Bcl-x L FLIP and b-actin were purchased from Sigma (Sigma Chemical Co., St Louis, MO, USA). MoAbs against Akt and phospho473-Akt were obtained from New England Biolabs (Beverly, MA, USA); MoAb specific for X-linked inhibitor of apoptosis protein (XIAP) from Medical & Biological Laboratories (Naka-Ku Nagoya, Japan); and MoAb specific for polyADP-ribose polymerase (PARP) was purchased from BD Biosciences Pharmingen. The anti-CD40 agonistic MoAb 89 was purchased from Immunotech (Marseille, France). Protein kinase inhibitors Wortmannin (Wm), PD 98059 (Calbiochem, La Jolla, CA, USA), and LY294002 (Cell Signaling Technologies, Beverly, MA, USA) were dissolved in DMSO and further diluted in cell culture medium before use at 100 nM, 10 mM, and 20 mM final concentrations, respectively (final concentration of DMSO did not exceed 0.05%).
Cell cultures
Purified normal and leukemic B lymphocytes were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco, Paisley, UK), 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. For activation through the CD40 antigen, freshly purified B-CLL cells were cultured in the presence of the anti-CD40 MoAb 89 presented by a mouse Ltk À cell line stably expressing CD32 (CD32 L cells), which was kindly provided by J Banchereau. Briefly, 5 Â 10 5 B cells were cultured in 24-well flat-bottom plates under a final volume of 1 ml with 5 Â 10 4 mitomycin C-treated CD32 L cells and the anti-CD40 MoAb (0.5 mg/ml). In some experiments, B cells were preincubated with the inhibitors Wm, LY294002, and PD 98059 for 30 min with and without the anti-CD40 MoAb 89. In all the experiments in which PI3K inhibitors were used, DMSO 0.05% was added to the control wells that contained the culture medium alone. Cell activation was assesed by flow cytometry using anti-CD69, anti-CD95, anti-CD25, anti-CD80, and anti-CD38 MoAbs.
Cell surface staining
Cell staining was performed by direct immunofluorescence. Briefly, peripheral blood mononuclear cells or purified B lymphocytes were resuspended in PBS and washed prior incubation for 20 min with the MoAbs at room temperature. Antibodies used for cell surface staining were purchased from BD Bioscences. Flow cytometric analyses were performed on a FACSort (Becton Dickinson) using the CellQuest software system.
Proliferation assay
Purified B-CLL cells were cultured on confluent Ltk À monolayers in the presence or absence of anti-CD40 MoAb 89 for 5 days. Bromodeoxyuridine (BrdU) was added for the last 18 h of culture. B cells were then recovered and the percentage of proliferating cells was analyzed by flow cytometry using a proliferation kit (BrdU Flow kit, BD Bioscences), according to the manufacturer's instructions.
Measurement of apoptosis by annexin V/propidium iodide double staining
Apoptotic cells were quantified by flow cytometry after annexin V-FITC and propidium iodide (PI) labelling. Briefly, 10 5 cells were washed with ice-cold PBS and were incubated for 15 min in the dark in 50 ml of binding buffer containing annexin V-FITC/ solution (Roche, Barcelona, Spain) and 10 mg/ml PI (Sigma).
Analysis of cytoskeletal morphology
To stain filamentous actin (F-actin) for flow cytometry, cells were fixed with PBS containing 3.7% formaldehyde for 1 h on ice and then left for 2 h in PBS containing 0.1% triton X-100 and 200 mU Bodipy 558/568-phalloidin (Molecular Probes, Leiden, Netherlands) at room temperature. The cells were then resuspended in PBS and analyzed by flow cytometry.
Measurement of caspase-3 activation
Activation of caspase-3 was quantified by flow cytometry. Briefly, 5 Â 10 5 cells fixed with 3.7% formaldehyde in PBS for 10 min on ice. The fixed cells were washed with PBS and then incubated for 10 min in PBS containing 0.1% triton X-100, 1.5% fetal bovine serum prior incubation at 41C for 30 min with the specific antiactive caspase-3 antibodies.
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Total RNA was extracted from 3 to 5 Â 10 6 B-CLL cells using guanidinium thiocyanate method (TRI ZOL , Gibco). The obtained RNA was reverse transcribed into cDNA using 20U AMV reverse transcriptase (Roche), according to the manufacturer's instructions. cDNA was then amplified by PCR in a Gene AmpPCR system 2400 cycler (Perkin Elmer, Norwalk, CT, USA). The PCR reaction was performed in 50 ml with 0.2 mM dNTPs, 1 Â GeneAmp buffer (15 mM MgCl 2 ) (Amersham Biosciences, Little Chalfont, UK), 1 U Taq DNA polymerase (Amersham Biosciences), and 0.4 mM of 5 0 ACT TGT GGC CCA GAT AGG CAC CCA G 3 0 (forward) and 5 0 CGA CTT CGC CGA GAT GTC CAG CCA G 3 0 (reverse) for bcl-2, and 5 0 TTG GAC AAT GGA CTG GTT GA 3 0 (forward) and 5 0 GTA GAG TGG ATG GTC AGT G 3 0 (reverse) for bcl-x L (Tib Biomol, Berlin, Germany). 18S rRNA primers and competimers (QuantumRNAt 18S, Ambion, Huntingdon, UK) were added into the PCR reaction as internal standard for relative quantitation. Cycling conditions were as follows: 1 cycle at 941C for 5 min, 30 cycles at 941C for 30 s, 601C for 1 min, 721C for 30 s, and a final extension at 721C for 5 min. Cycling conditions for bcl-x L included 10 previous cycles with an annealing temperature of 701C and then 20 cycles at 601C. In total, 10 ml of each sample was subjected to separation by electrophoresis in 2% agarose gel and stained with ethidium bromide. Densitometric analyses were performed using the Quantity One s software system (Bio-Rad Laboratories, Hercules, CA, USA).
Western blotting
Cellular lysates equivalent to 5 Â 10 6 B cells were prepared using a lysis buffer containing 50 mM Tris, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 2 mM phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin and, as appropriate, with the phosphatase inhibitor Na orthovanadate (0.1 mM). Protein concentrations were determined using the BCA protein assay kit (Pierce, Rockford, IL, USA). Cell lysates were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and blotting was performed on polyvinylidene difluoride membranes (Amersham Biosciences). Blots were developed using an enhanced chemilumiscence detection system (Amersham Biosciences). For some analyses the blots were reprobed after exposure to stripping buffer (100 mM b-mercaptoethanol, 2% SDS, 62.5 mM Tris, pH 6.8) for 30 min at 501C. Densitometric analyses were performed using the Quantity One software system (Bio-Rad).
Electrophoretic mobility shift assay (EMSA)
Nuclear proteins extraction and generation of 32 P end-labelled probe were performed as reported previously. 39 Nuclear proteins (2 mg) were incubated for 10 min in a final volume of 10 ml with 200 ng poly(dIdC) (Amersham Biosciences) before addition of 0.4 ng of 5 0 -end labelled ds-oligonucleotide kB, which contains an NF-kB binding site (5 0 CAA CGG CAG GGG AAT CTC CCT CTC CTT 3 0 ). 40 Binding reactions were allowed during 30 min at room temperature and electrophoresed in a 5% polyacrylamide gel in TBE (0.5 Â ). DNA-protein complexes were detected by X-ray film exposition. Every reaction was assayed twice. For supershift assays, the binding mixtures were preincubated with the indicated antibody for 3 h before adding the end-labelled probe. Competition assays were carried out in the presence of a 50-fold molar excess of cold oligonucleotide 10 min before the addition of the probe. An oligonucleotide with a sequence not recognized by NF-kB was used as an unrelated competitor. 39 
Results
In vitro apoptosis of B-CLL cells is temporally associated with downregulation of bcl-x L , which is prevented by contact with Ltk À mouse fibroblasts
Proclivity of B-CLL cells to spontaneous apoptosis in vitro may be associated with loss of expression of antiapoptotic proteins resulting from disruption of microenvironmental survival signals. To study key signaling events involved in the transmission of these survival signals, we first examined the effect of Ltk À coculture on malignant cell survival and on bcl-2 and bcl-x L expression using CD40 ligation as a control for comparison. For these experiments, purified B cells from nine CLL patients were cultured with conventional culture medium alone or on mitomycin-treated confluent Ltk À fibroblasts in the presence or absence of an agonistic MoAb to CD40. B-CLL cells were then recovered every 24 h for up to 5 days, and bcl-2 and bcl-x L mRNA levels were analyzed by RT-PCR. At the same time points the percentage of surviving B-CLL cells was quantified by annexin V/PI double staining followed by flow cytometric analysis. As illustrated in Figure 1a , B-CLL cells cultured in culture medium alone showed a dramatic increase of apoptosis after 72 h of culture, which was highly prevented by contact The PI3K/NF-jB pathway and apoptosis of B-CLL cells S Cunı´et al with Ltk À cells. Anti-CD40 presented by Ltk À did not increase significantly the effect of Ltk À in promoting B-CLL cell survival probably because the presence of Ltk À alone was sufficient for preventing apoptosis.
On the other hand, B-CLL cells cultured in the culture medium alone showed stable high expression of bcl-2 over the 5-day culture period (Figure 1b, left panel) , indicating that the high constitutive expression of bcl-2 alone was insufficient to prevent apoptosis in vitro. By contrast, bcl-x L mRNA levels were rapidly reduced in B-CLL cells upon culture in the culture medium for 24 h (data not shown). After 72 h of culture there were no detectable levels of bcl-x L while coculture with Ltk À cells prevented bcl-x L downregulation (Figure 1b , right panel). CD40 crosslinking did not further increase the high constitutive expression of bcl-2 (data not shown), but notably upregulated bcl-x L expression, as previously described in normal B cells. 41, 42 Based on the finding that spontaneous apoptosis was associated with reduction of bcl-x L expression, we postulated that the signaling pathway involved in bcl-x L regulation in CLL cells could be crucial for their survival.
Spontaneous apoptosis of B-CLL cells is prevented by Ltk
À murine fibroblasts via the PI3K pathway
In many cell types, matrix attachment has been shown to result in activation of the PI3K/Akt and Raf-MEK-Erk pathways, 43, 44 protecting epithelial and endothelial cells against matrix detachment-induced cell death. 45, 46 We then evaluated the possibility that the Raf-Mek-Erk and the PI3K/PKB pathways would be involved in the promotion of B-CLL cells survival mediated by Ltk À . To this purpose, B-CLL cells were preincubated with the Raf inhibitor PD 98059 and the PI3K inhibitor Wm before culture with Ltk À cells. In initial experiments, PD 98059 and Wm inhibitors were tested over a range of doses and determined that there was no significant effect in cell viability in B-CLL cells cultured in the absence of Ltk À fibroblasts with doses up to 10 mM and 100 nM, respectively. The inhibition of MEK did not reverse Ltk À -induced protection of B-CLL cells from apoptosis, whereas the inhibition of PI3K activity abrogated almost completely the Ltk À -mediated B-CLL cell survival in 14 cases analyzed, as measured by annexin-V/PI double staining (Figure 2a, left panel) . The organization of cytoskeletal is known to be sensitively affected in cells undergoing apoptosis. 47 To confirm the results obtained on annexin V/PI double staining, we used the disruption of F-actin organization, measured as F-actin-specific fluorescence from bodipy 558/ 568-conjugated phalloidin, as a marker of apoptosis. Flow cytometric measurements of F-actin-specific fluorescence showed a clear decrease in F-actin staining in those cells that had been cultured in the culture medium alone for 48 h, whereas Ltk À coculture prevented the decrease in F-actin staining (Figure 2a, right panels) . Preincubation of cells with Wm before being cultured on Ltk À monolayers inhibited Ltk À -mediated protection from apoptosis. Therefore, it appears that interactions with Ltk À cells protect B-CLL cells from spontaneous apoptosis through the PI3K but not through the Raf-MEKErk pathway.
The possibility that PI3K might regulate the expression of bcl-x L in B-CLL cells was explored. Densitometric analysis of RT-PCR products in five CLL cases tested showed that Ltk To confirm that Ltk À coculture induces PI3K activity in CLL cells, we analyzed Akt activation by Western blotting using antibodies specific for the active form, which is phosphoylated at Ser 473 . Densitometric analysis from three separate specimens revealed that Akt phosphorylation was readily evident in freshly isolated B-CLL cells (no culture, Figure 3a (Figure 3b and d) . As recent evidence showed that Akt activity is also involved in cell cycle progression, [48] [49] [50] [51] we investigated the possibility that CD40-triggered increase in Akt phosphorylation might be associated with activation and proliferation of B-CLL cells in vitro. Changes in cell size (Figure 4a ) and the upregulation of several lymphocyte activation markers (data not shown) in response to CD40-mediated signals were firstly analyzed by flow cytometry. Then, the proliferative response of B-CLL cells to CD40 engagement was assessed by 5-bromo-2-deoxyuridine (BrdU) incorporation. As shown in Figure 4b , CD40 crosslinking increased the percentage of B cells that incorporate BrdU compared with cells cultured with Ltk À alone (negative control) in all six CLL samples analyzed. In order to test the role of PI3K in the CD40-mediated B-CLL cell proliferation, cells were incubated with Wm before stimulation with anti-CD40. PI3K inhibition abrogated completely the induction of DNA synthesis (data not shown), indicating that CD40 crosslinking induces B-CLL cell proliferation via PI3K.
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PI3K/Akt activity prevents caspase-3 activation in B-CLL cells
Given that PI3K has been shown to protect cells from apoptosis in a caspase-dependent manner, 52,53 the role of PI3K in caspase inhibition was examined in seven CLL cases. After 48 h of culture in medium alone, B-CLL cells presented a high percentage of activated caspase-3 as measured by flow cytometry using specific antibodies for the active form. However, the percentage of caspase-3 activation was clearly reduced in those cells that had been cocultured with Ltk À . When cells were incubated with Wm before culturing with Ltk À , the percentage of activated caspase-3 was similar to that observed in B-CLL cells cultured in medium alone (Figure 5a and b), indicating that maintenance of the PI3K pathway is required to prevent the activation of caspase-3. As PARP is cleaved by caspase-3 to yield an 85-kDa product signature, we analyzed PARP fragmentation by Western blot to confirm the findings of caspase-3 activation. The results of PARP cleavage were always similar to data of flow cytometric analysis (Figure 5c ). In the presence of Ltk À all PARP is present in its intact form, whereas after preincubation with Wm the proportion of cleaved PARP is equivalent to that of the cells cultured in the culture medium alone.
PI3K/Akt activity results in activation of NF-kB in B-CLL cells
It has been shown that B-CLL cells exhibit high constitutive levels of NF-kB activity. 38 Since there were previous reports linking NF-kB activity to the activation of Akt, and others demonstrating bcl-x L as an NF-kB target gene, our findings suggested that NF-kB could be implicated in the Ltk À -mediated B-CLL cell survival (downstream of PI3K). On the other hand, it was previously confirmed that the NF-kB-mediated increase of (Figure 6a , right panels). Densitometric analysis in three CLL specimens tested showed that immediately upon isolation (no culture) B-CLL cells presented high levels of NF-kB activity. However, culture with the culture medium alone resulted in the loss of NFkB activity within 12 h (data not shown). Consistent with our previous findings, Ltk À coculture sustained a moderate level of NF-kB activity in B-CLL cells and Wm abrogated the NF-kB activity mediated by Ltk À (Figure 6a , right panels). Furthermore and in agreement with other studies, 38 stimulation of B-CLL cells with anti-CD40 induced high levels of NF-kB activity. To confirm the specificity of the NF-kB signal, a cold oligonucleotide competition assay with 50-fold molar excess of an unlabeled and unrelated competitor 39 was used (Figure 6b ). Supershift assay showed that NF-kB complexes translocated predominantly p50-p65 heterodimers to the nuclear extracts (Figure 6c ), as previously reported in normal and B-CLL cells. 55 These observations indicate that Ltk À -mediated activation of PI3K leads to NF-kB activity and that such activity may be involved in the protection of B-CLL cells from spontaneous apoptosis.
According to the findings of a correlation between PI3K activation and caspase-3 inhibition as well as of NF-kB activation by PI3K activity, it was postulated that caspase-3 inhibition could be mediated by NF-kB target proteins known to inhibit caspase activity. To test this hypothesis we determined the expression of X-linked inhibitor of apoptosis protein (XIAP) and FLIP L proteins by Western blotting in B-CLL cells after 48 h of culture in the culture medium alone, with Ltk À without or upon preincubation with Wm, and with Ltk À and anti-CD40. Both FLIP L and XIAP were upregulated in cells cultured with Ltk À -mediated PI3K activity leads to NF-kB activation in B-CLL cells. B-CLL cells from specimens of three patients were cultured in the culture medium alone (containing 0.05% DMSO), with Ltk À cells without or upon preincubation with Wm, and with Ltk À cells and anti-CD40 MoAb. (a) Nuclear extracts were prepared from B-CLL cells immediately after purification (no culture, left panel) or after 48 h of culture (right panels, ns denotes nonspecific bands). A total of 5 mg of protein from each nuclear extract were analyzed for NF-kB activity by EMSA using a labelled probe for NF-kB binding activity. (b) To confirm the specificity of the signals for NF-kB activity the nuclear extracts were incubated with the labelled oligonucleotide in the presence or absence of a 50-fold molar excess of an unrelated and unlabelled competitor or NF-kB-binding oligonucleotides. (c) Nuclear extracts were analyzed for specific NF-kB proteins by supershift EMSA using polyclonal rabbit antibodies to p50, p52, p65, and c-Rel, n specific NF-kB signal).
Discussion
Malignant B-CLL cells in vivo display an enhanced survival and their level of apoptosis remains low compared with that of normal B lymphocytes. By contrast, in vitro B-CLL cells die spontaneously and are difficult to keep alive. This observation suggests that the malignant cell survival depends upon supportive interactions within specific microenvironments. It has been reported that B-CLL cells accumulate in the bone marrow and in neoplastic follicules, where they receive survival or growth signals from bystander cells. 56, 57 One fundamental stimulus in the bone marrow microenvironment is that mediated by CD40. Owing to its antiapoptotic properties, this molecule is believed to exert profound influences on the growth of B lymphocytes and to direct T-lymphocyte-mediated rescue of germinal center B cells. 9, 10, 58 Furman et al 38 showed that CD40 ligation inhibits apoptosis in CLL cells by inducing the transcription factor NF-kB. On the other hand, human bone marrow stromal cells have been described to prevent apoptosis and support the survival of B-CLL cells in vitro. 5, 6 Experimental evidences have demonstrated that the murine Ltk À cell line can substitute for human bone marrow stromal feeder cells in vitro. 15 In an attempt to determine the molecular mechanisms involved in the survival and growth pattern of B-CLL cells, we used the Ltk À cell line in the presence or absence of an anti-CD40 MoAb, as a model to mimic in vivo tumor microenvironment.
It was observed that B-CLL cell proclivity to apoptosis was temporarily associated with downregulation of bcl-x L . Ltk À coculture prevented both spontaneous apoptosis and Bcl-x L downregulation by a PI3K-dependent mechanism. The expression of this antiapoptotic protein decreased rapidly upon cell culturing explaining why our data probably differ from those previously reported. The inhibition of the MAPK pathway had no significant effect in the Ltk We detected constitutive Akt phosphorylation and NF-kB activation in freshly purified B-CLL cells. However, both Akt and NF-kB activity decreased quickly once cultured in vitro, suggesting that in vivo activation may be maintained by microenvironmental factors. These findings are in agreement with previous reports showing that B-CLL cells exhibit high constitutive levels of NF-kB activity compared with nonmalignant human B cells. 38 Bernal et al 59 have reported that NF-kB activity was reduced in B-CLL cells after 4 h of culture in conventional culture medium. In the same study, these authors showed that together with CD40 ligation, engagement of the B cell receptor promotes both, PI3-K/Akt and NF-kB activity, and consequently B-CLL survival.
Bcl-x L has been identified as an NF-kB target gene in other cellular types. 36, 60 We have shown that interaction with Ltk The PI3K/NF-jB pathway and apoptosis of B-CLL cells S Cunı´et al x L protein (as shown by Western blot) (Figure 2b ). Since inhibition of PI3K with Wm also inhibited NF-kB activity, it may be postulated that PI3K induces Bcl-x L expression in B-CLL cells via NF-kB activation. The Akt and NF-kB activity induced by Ltk À correlated with caspase-3 inhibition and promotion of B-CLL cell survival. Recent evidence has implicated Akt as a signaling intermediate upstream of survival gene expression that is dependent on NFkB activation. 16 Moreover, in our study, the PI3K-dependent NF-kB activity mediated by Ltk À resulted in the expression of XIAP and FLIP L , which are known to bind and inhibit the activity of the effector caspases 7 and 3 61 and caspase 8, 62 respectively, probably preventing apoptosis of B-CLL cells. The levels of Akt phosphorylation and NF-kB activity, as well as the expression of the antiapoptosis proteins Bcl-x L and FLIP L , were further increased in B-CLL cells stimulated by anti-CD40. However, interaction with Ltk À cells alone resulted in PI3K-and Aktmediated survival signs, which were sufficient to maintain the cells viable. Additional CD40 crosslinking would further enhance PI3K and NF-kB activity levels, which may lead to B-CLL cell proliferation.
The presence of proliferation centers in lymphoid tissues from most CLL cases has been described. These are follicle-like structures which have been suggested to be the centers of antigen-driven proliferation. 63 In addition, the presence of CD4 þ T cells expressing CD40L in the proliferation centers and in the microenvironment of the bone marrow has been shown. 13, 64 All these findings suggest that B-CLL cells in vivo might have special niches, where they receive growth signals probably through CD40 and through the B cell receptor, leading to a high PI3K and NF-kB activity levels and, consequently, to the expansion of the malignant clone. The survival of the resulting cells might be dependent on a basal level of PI3K/Akt and NF-kB activities, which probably are maintained by interactions with the extracellular matrix and stromal cells. This basal level of activity would be sufficient for their extended survival, allowing them to reach again a proliferation promoting microenvironment. Finally, our finding that the PI3K-mediated signaling pathway is critical in the survival and growth of B-CLL cells suggests that chemotherapeutic intervention at various points along the pathway may facilitate the entry of B-CLL cells into apoptosis. Blockade of the PI3K pathway might also prevent the expansion of the malignant clone of B cells. Precise definition of the components of the PI3K transduction pathway critical for the survival of B-CLL cells may potentially offer several attractive targets for new therapies in this disease. For example, it has been recently demonstrated that Akt stimulates NF-kB predominantly by upregulating the transactivation potential of p65, and that activated Akt requires IKK to efficiently stimulate the transactivation domain of the p65 subunit of NF-kB. 29 Then, small molecule inhibitors of the NFkB-inducing kinases, IKKa and IKKb, 65 and proteasome inhibitors that prevent IkB degradation 66, 67 could find applicability for the treatment of the disease.
